Today: 7 February 2026
Subscribe
Browse Category

NSE:AUSFB News 10 December 2025 - 27 December 2025

Bombay Stock Exchange Today: Sensex Slips on Year-End Profit-Taking as BSE Bankex Revamp Kicks In

Bombay Stock Exchange Today: Sensex Slips on Year-End Profit-Taking as BSE Bankex Revamp Kicks In

NEW YORK, Dec. 27, 2025, 8:32 a.m. ET — Market closed The Bombay Stock Exchange (BSE) is shut for the weekend, but Dalal Street is ending 2025’s final stretch with a familiar year-end cocktail: record-adjacent index levels, thinner participation, and investors trying to separate “healthy consolidation” from “quietly rising risk.” When trading last wrapped up on Friday, the S&P BSE Sensex fell 0.43% to 85,041.45, while the NSE Nifty 50 dropped 0.38% to 26,042.3—moves widely framed as profit-taking near highs in holiday-thinned conditions. Reuters+1 Sensex and Nifty: weekly gains survived, but momentum cooled Even with Friday’s dip, benchmarks still managed
27 December 2025
····
Top Stock Gainers in India Today (December 10, 2025): Highway Infrastructure, Meesho, Sammaan Capital, AU SFB and Hindustan Zinc in Focus

Top Stock Gainers in India Today (December 10, 2025): Highway Infrastructure, Meesho, Sammaan Capital, AU SFB and Hindustan Zinc in Focus

The Indian stock market spent much of Wednesday in “wait-and-watch” mode ahead of the US Federal Reserve’s policy outcome, but that didn’t stop a clutch of stocks from delivering eye-catching gains across the NSE and BSE. While the Sensex and Nifty 50 hovered near flatline levels around midday, action in select infrastructure, financials, metals and freshly listed IPOs was anything but quiet.Business Standard+ 1 Below is a news‑style roundup of today’s biggest gainers on the Indian stock market (10 December 2025) , along with the key triggers, analyst commentary and technical forecasts shaping sentiment. Market snapshot: Indices flat, stock‑specific fireworks
10 December 2025
··

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop